Prev  |  Next
No More Skip Forward
Unthreaded  |  Threaded Author Recs Date Number
JNJ's new prostate cancer advances... duuude1 2 6/6/2017 3:06 PM 10422
Merck’s Mammen joins JNJ to head R&D... duuude1 1 6/9/2017 12:39 PM 10423
JNJ Drug Prevents Heart Attacks At Cost Of... duuude1 -- 6/13/2017 6:22 AM 10424
JNJ sets out to build a new R&D group... duuude1 1 6/16/2017 11:14 AM 10425
U.S. Supreme Court ruling threatens massive talc duuude1 1 6/21/2017 5:11 AM 10426
Why JNJ Is Valued at Its Highest P/E in Decade.. duuude1 2 7/8/2017 5:14 PM 10427
Will JNJ's Dividend Keep Climbing? duuude1 2 7/9/2017 5:07 AM 10428
Re: Why JNJ Is Valued at Its Highest P/E in Deca dlbuffy 1 7/10/2017 2:11 PM 10429
Re: Why JNJ Is Valued at Its Highest P/E in Deca jaroman 1 7/13/2017 7:57 PM 10430
Despite Falling Drug Sales, JNJ Remains... duuude1 2 7/20/2017 7:43 AM 10431
JNJ Is A Defensive Stock And Should Be... duuude1 1 7/22/2017 5:59 AM 10432
FDA: JNJ arthritis drug sirukumab... duuude1 2 8/1/2017 9:19 AM 10433
Re: FDA: JNJ arthritis drug sirukumab... duuude1 1 8/3/2017 6:48 AM 10434
An open letter to J&J CoB & CEO Alex Gorsky... duuude1 8 8/16/2017 8:50 PM 10435
Re: An open letter to J&J CoB & CEO Alex Gorsky. Wradical 12 8/17/2017 12:07 PM 10436
Re: An open letter to J&J CoB & CEO Alex Gorsky. mjolah 7 8/17/2017 1:10 PM 10437
J&J Loses $417 Million Talc Verdict... duuude1 -- 8/21/2017 3:43 PM 10438
Re: J&J Loses $417 Million Talc Verdict... jaroman 1 8/21/2017 3:44 PM 10439
Re: J&J Loses $417 Million Talc Verdict... timothyrussell -- 8/22/2017 5:22 AM 10440
Pfizer sues Johnson & Johnson... duuude1 -- 9/20/2017 9:40 PM 10441
Prev  |  Next
No More Skip Forward
Advertisement